title: Blood monocytes and tumor-associated macrophages in human cancer: differences in activation levels.
abstract: This study was performed to investigate functional properties of mononuclear phagocytes isolated from ascitic fluid in patients with peritoneal carcinomatosis (PC), and potential immunomodulatory effects of soluble factors produced or induced by human metastatic malignant cells. Phagocytic activity and nitric oxide production of peripheral blood monocytes (PBMo) and tumor-associated macrophages (TAM) or peritoneal macrophages (PEM) were synchronously examined in cancer patients and control individuals. Our results showed that contrary to peripheral blood monocytes, where phagocytic activity was not altered, TAM had impaired phagocytic activity. Moreover, dilutions of crude supernatant from short-term cultures of the peritoneal cells obtained from ascitic fluid of patient with PC, cause a significant, dose dependent inhibition of control PBMo and PEM phagocytosis, comparable to those in TAM, indicating that a soluble factor(s) plays a prominent role in this alteration. Next, we investigated the potential of cancer patients mononuclear phagocytes to produce nitric oxide (NO). It was found that TAM produce fourfold lower levels of NO than PEM from control subject, whereas monocytes produce NO at levels comparable to those of corresponding controls. These data support the hypothesis that depressed TAM function may contribute to the mechanisms of tumor escape from immune destruction.
authors.affiliation: Institute of Microbiology and Immunology, Faculty of Medicine, University of Kragujevac, Yugoslavia. baskic@medicus.medf.kg.ac.yu
authors.forename: D
authors.initials: D
authors.lastname: Baskic
authors.forename: L
authors.initials: L
authors.lastname: Acimovic
authors.forename: G
authors.initials: G
authors.lastname: Samardzic
authors.forename: N L
authors.initials: NL
authors.lastname: Vujanovic
authors.forename: N N
authors.initials: NN
authors.lastname: Arsenijevic
mesh_terms: D000276:Adjuvants, Immunologic; D001202:Ascitic Fluid / Q000166:cytology / Q000276:immunology; D002277:Carcinoma / Q000276:immunology*; D016022:Case-Control Studies; D006801:Humans; D008264:Macrophages / Q000276:immunology*; D009000:Monocytes / Q000276:immunology*; D009569:Nitric Oxide / Q000096:biosynthesis; D010534:Peritoneal Neoplasms / Q000276:immunology*; D010587:Phagocytosis / Q000276:immunology
chemical_list: D000276:Adjuvants, Immunologic; D009569:Nitric Oxide